These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9038296)

  • 21. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization.
    Wu HY; Nikolova EB; Beagley KW; Eldridge JH; Russell MW
    Infect Immun; 1997 Jan; 65(1):227-35. PubMed ID: 8975916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
    Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
    J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of female genital tract antibody responses by local or central (common) mucosal immunization.
    Wu HY; Abdu S; Stinson D; Russell MW
    Infect Immun; 2000 Oct; 68(10):5539-45. PubMed ID: 10992451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization.
    Hajishengallis G; Russell MW; Michalek SM
    Infect Immun; 1998 Apr; 66(4):1740-3. PubMed ID: 9529105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant.
    Wilson AD; Bailey M; Williams NA; Stokes CR
    Eur J Immunol; 1991 Oct; 21(10):2333-9. PubMed ID: 1833201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
    Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
    Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.
    Harokopakis E; Hajishengallis G; Greenway TE; Russell MW; Michalek SM
    Infect Immun; 1997 Apr; 65(4):1445-54. PubMed ID: 9119486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue.
    Wu HY; Nikolova EB; Beagley KW; Russell MW
    Immunology; 1996 Aug; 88(4):493-500. PubMed ID: 8881748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
    Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
    Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
    Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
    Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.
    Tinker JK; Yan J; Knippel RJ; Panayiotou P; Cornell KA
    Toxins (Basel); 2014 Apr; 6(4):1397-418. PubMed ID: 24759174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host defense against cholera toxin is strongly CD4+ T cell dependent.
    Hörnqvist E; Goldschmidt TJ; Holmdahl R; Lycke N
    Infect Immun; 1991 Oct; 59(10):3630-8. PubMed ID: 1910010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system.
    Salam MA; Katz J; Zhang P; Hajishengallis G; Michalek SM
    Vaccine; 2006 Jun; 24(23):5003-15. PubMed ID: 16621196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
    Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
    J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
    Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
    Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.
    Lycke N; Holmgren J
    Infect Immun; 1989 Apr; 57(4):1137-41. PubMed ID: 2784416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits.
    Hajishengallis G; Hollingshead SK; Koga T; Russell MW
    J Immunol; 1995 May; 154(9):4322-32. PubMed ID: 7722290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.